IBDEI02Z ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3678,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,3679,0)
 ;;=V15.07^^36^277^49
 ;;^UTILITY(U,$J,358.3,3679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3679,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,3679,1,5,0)
 ;;=5^Personal H/O Allerlgy To Latex
 ;;^UTILITY(U,$J,358.3,3679,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,3680,0)
 ;;=V13.4^^36^277^50
 ;;^UTILITY(U,$J,358.3,3680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3680,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,3680,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,3680,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,3681,0)
 ;;=V12.72^^36^277^51
 ;;^UTILITY(U,$J,358.3,3681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3681,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,3681,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,3681,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,3682,0)
 ;;=V12.59^^36^277^52
 ;;^UTILITY(U,$J,358.3,3682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3682,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,3682,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,3682,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,3683,0)
 ;;=V45.81^^36^277^53
 ;;^UTILITY(U,$J,358.3,3683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3683,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,3683,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,3683,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,3684,0)
 ;;=V15.84^^36^277^54
 ;;^UTILITY(U,$J,358.3,3684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3684,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,3684,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,3684,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,3685,0)
 ;;=V15.85^^36^277^60
 ;;^UTILITY(U,$J,358.3,3685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3685,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,3685,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,3685,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,3686,0)
 ;;=V10.72^^36^277^56
 ;;^UTILITY(U,$J,358.3,3686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3686,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,3686,1,5,0)
 ;;=5^Personal H/O Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,3686,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,3687,0)
 ;;=V15.3^^36^277^57
 ;;^UTILITY(U,$J,358.3,3687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3687,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,3687,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,3687,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,3688,0)
 ;;=V10.61^^36^277^32
 ;;^UTILITY(U,$J,358.3,3688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3688,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,3688,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,3688,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,3689,0)
 ;;=V12.03^^36^277^33
 ;;^UTILITY(U,$J,358.3,3689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3689,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,3689,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,3689,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,3690,0)
 ;;=V10.82^^36^277^34
 ;;^UTILITY(U,$J,358.3,3690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3690,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,3690,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,3690,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,3691,0)
 ;;=V10.62^^36^277^36
 ;;^UTILITY(U,$J,358.3,3691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3691,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,3691,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,3691,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,3692,0)
 ;;=V10.63^^36^277^35
 ;;^UTILITY(U,$J,358.3,3692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3692,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,3692,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,3692,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,3693,0)
 ;;=V11.2^^36^277^30
 ;;^UTILITY(U,$J,358.3,3693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3693,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,3693,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,3693,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,3694,0)
 ;;=V15.81^^36^277^46
 ;;^UTILITY(U,$J,358.3,3694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3694,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,3694,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,3694,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,3695,0)
 ;;=V10.43^^36^277^37
 ;;^UTILITY(U,$J,358.3,3695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3695,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,3695,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,3695,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,3696,0)
 ;;=V12.71^^36^277^38
 ;;^UTILITY(U,$J,358.3,3696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3696,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,3696,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,3696,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,3697,0)
 ;;=V10.46^^36^277^39
 ;;^UTILITY(U,$J,358.3,3697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3697,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,3697,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,3697,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,3698,0)
 ;;=V11.0^^36^277^40
 ;;^UTILITY(U,$J,358.3,3698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3698,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,3698,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,3698,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,3699,0)
 ;;=V10.83^^36^277^41
 ;;^UTILITY(U,$J,358.3,3699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3699,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,3699,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,3699,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,3700,0)
 ;;=V15.1^^36^277^42
 ;;^UTILITY(U,$J,358.3,3700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3700,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,3700,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,3700,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,3701,0)
 ;;=V15.82^^36^277^44
 ;;^UTILITY(U,$J,358.3,3701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3701,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,3701,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,3701,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,3702,0)
 ;;=V12.01^^36^277^43
 ;;^UTILITY(U,$J,358.3,3702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3702,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,3702,1,5,0)
 ;;=5^Hx Of Tb
 ;;^UTILITY(U,$J,358.3,3702,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,3703,0)
 ;;=V13.01^^36^277^31
 ;;^UTILITY(U,$J,358.3,3703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3703,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,3703,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,3703,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,3704,0)
 ;;=V12.51^^36^277^45
 ;;^UTILITY(U,$J,358.3,3704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3704,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,3704,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,3704,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,3705,0)
 ;;=V17.89^^36^277^3
 ;;^UTILITY(U,$J,358.3,3705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3705,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,3705,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,3705,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,3706,0)
 ;;=V12.54^^36^277^29
 ;;^UTILITY(U,$J,358.3,3706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3706,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,3706,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,3706,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,3707,0)
 ;;=V12.54^^36^277^28
 ;;^UTILITY(U,$J,358.3,3707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3707,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,3707,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,3707,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,3708,0)
 ;;=V15.88^^36^277^26
 ;;^UTILITY(U,$J,358.3,3708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3708,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,3708,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,3708,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,3709,0)
 ;;=V13.59^^36^277^27
 ;;^UTILITY(U,$J,358.3,3709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3709,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,3709,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,3709,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,3710,0)
 ;;=V12.04^^36^277^58
 ;;^UTILITY(U,$J,358.3,3710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3710,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,3710,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,3710,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,3711,0)
 ;;=V62.22^^36^277^61
 ;;^UTILITY(U,$J,358.3,3711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3711,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,3711,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,3711,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,3712,0)
 ;;=V13.51^^36^277^59
 ;;^UTILITY(U,$J,358.3,3712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3712,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,3712,1,5,0)
 ;;=5^Personal H/O Pathological FX
 ;;^UTILITY(U,$J,358.3,3712,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,3713,0)
 ;;=V15.51^^36^277^63
 ;;^UTILITY(U,$J,358.3,3713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3713,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,3713,1,5,0)
 ;;=5^Personal H/O Traumatic FX
 ;;^UTILITY(U,$J,358.3,3713,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,3714,0)
 ;;=V15.52^^36^277^62
 ;;^UTILITY(U,$J,358.3,3714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3714,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,3714,1,5,0)
 ;;=5^Personal H/O Traumatic Brain Injury
 ;;^UTILITY(U,$J,358.3,3714,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,3715,0)
 ;;=V70.0^^36^278^2
 ;;^UTILITY(U,$J,358.3,3715,1,0)
 ;;=^358.31IA^5^2
